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Abstract
Background: The bacterial CRISPR system is fast becoming the most popular genetic and epigenetic engineering
tool due to its universal applicability and adaptability. The desire to deploy CRISPR-based methods in a large variety
of species and contexts has created an urgent need for the development of easy, time- and cost-effective methods
enabling large-scale screening approaches.
Results: Here we describe CORALINA (comprehensive gRNA library generation through controlled nuclease activity),
a method for the generation of comprehensive gRNA libraries for CRISPR-based screens. CORALINA gRNA libraries
can be derived from any source of DNA without the need of complex oligonucleotide synthesis. We show the
utility of CORALINA for human and mouse genomic DNA, its reproducibility in covering the most relevant
genomic features including regulatory, coding and non-coding sequences and confirm the functionality of
CORALINA generated gRNAs.
Conclusions: The simplicity and cost-effectiveness make CORALINA suitable for any experimental system. The
unprecedented sequence complexities obtainable with CORALINA libraries are a necessary pre-requisite for less
biased large scale genomic and epigenomic screens.
Keywords: gRNA library, Genome-wide, Cas9, Genetic engineering, Epigenetic engineering, Elongated protospacer,
Epigenome editing
Background
Reliable and efficient targeting has been the bottleneck
for functional genomic and epigenomic approaches for
decades. Recent research in bacterial DNA binding fac-
tors, however, provided new and highly customizable
options. Most prominently used to date is the CRISPR
system, which evolved in prokaryotic cells as a defense
mechanism against invading phages [1]. So far the
CRISPR system has been adapted to many cell types
and species, where, without exception and with a high
degree of specificity, robust genomic targeting of Cas9
(or modifications thereof, like the Cas9 nickase fusion
protein, Cas9n [2]) has been achieved through addition
of engineered guide RNA molecules (gRNAs) to those
genomic DNA sequences encoded by the protospacer
of the RNA sequence [3]. Endogenous Cas9 contains an
endonuclease domain enabling the introduction of
double strand breaks into genomic DNA [4]. Conse-
quently, to date the most common utilization of Cas9
(or Cas9 variants) is targeted modification of the gen-
ome sequence through mutation, deletion or insertion.
These approaches allow simple functional interrogation
of coding, but also of noncoding regions in the genome.
Promoters and enhancers [5], lncRNAs [6], miRNA
response elements [7], retroviruses [8], telomeres [9]
and introns [10] have already been successfully modi-
fied using CRISPR.
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Genome editing with CRISPR has proven remarkably
efficient [11], extending to cell types and species where
this was so far not (or only insufficiently) applicable (e.g.
plasmodium [12], Cryptosporidium [13], tunicates [14],
wheat [15], rice [16], tomato [17], silk worms [18], C.
elegans [19], beetles [20], sea lampreys [21], zebrafish
[22], salmons [23], pigs [24], rats [25], goats [26], rabbits
[27], and many more).
The simple and elegant concept of the CRISPR system
which only requires short gRNAs for targeting, allows
easy adaptation of this system to screening approaches.
A series of recent studies demonstrated the use of
screening approaches using pooled gRNA libraries for
functional genetics and to dissect therapeutically rele-
vant pathways (reviewed in [28]). Consequently, method
development for gRNA library generation for screening
is currently at the forefront of CRISPR research [29–31].
Screening libraries are, however, almost exclusively gen-
erated employing complex oligonucleotide synthesis,
limiting the size and dissemination of libraries substan-
tially due to technical restrictions and relatively high
costs. Hence, for human and mouse, only gRNA libraries
of limited complexity have been generated so far and
none are available for other mammals.
To unleash the full potential of CRISPR-based screen-
ing for the large variety of biological model systems,
new, simple, time- and cost-effective approaches are
urgently needed. Likewise, to expand current screening
approaches to the whole genome, including non-coding
regulatory regions (e.g. those identified by ChIP or HiC
approaches) [32] or to enable epigenetic screens [33],
more complex gRNA library pools are required. Due to
our current inability to predict which of the many genetic
and epigenetic variants identified e.g. by genome- and
epigenome-wide association studies are functional, we are
unable to restrict gRNA libraries specifically to the corre-
sponding relevant sites. CORALINA overcomes this limi-
tation by generating gRNA libraries with the potential to
cover virtually complete genomes in a simple, time- and
cost-effective procedure.
Methods
Construction of guide RNA plasmids
Plasmid pMLM3636 (plasmid ID 43860) was obtained
from Addgene, cut with BsmBI and a double-stranded
DNA fragment, generated by annealing the two oligos
MLM3636-1F (5′-ATCTTGTGGAAAGGACGAAA
CACCGGTTTTAGAGCTAGAAATAGCAAGTT) and
MLM3636-1R (5′-AACTTGCTATTTCTAGCTCTAA
AACCGGTGTTTCGTCCTTTCCACAAGAT), inserted
via Gibson cloning. This yields a modified vector,
pgRNA1 containing the U6 promoter, followed by the
5′G of the gRNA sequence and the scaffold sequence,
but lacking the targeting sequence. For lentiviral vector
construction, the vector pLKO.1 (Addgene plasmid
10878) was modified to insert the gRNA promoter and
scaffolding sequence from pgRNA1. The vector was
first digested with EcoRI (NEB) and AgeI (NEB). Next,
the desired sequences were amplified from pgRNA1
using primers gRNA-PLKO-F (5′-TTTCTTGGGTAG
TTTGCAGTTTT) and gRNA-PLKO-R (5′-ccatttgtctc
gaggtcgag-TACCTCGAGCGGCCCAAGC) and inserted
into PLKO.1. This vector is referred to as pgRNA-
pLKO.1.
Construction of gRNA libraries from MNase-digested
genomic DNA
Human genomic DNA extracted from pooled male and
female blood (250 ng/μl, provided by the Personal Gen-
ome Project UK (PGP-UK) under UCL Ethics approval
4700/001) or mouse genomic DNA (Promega) was
digested with various amounts of micrococcal nuclease
(NEB) to determine the optimal amount of enzyme for
fragmenting genomic DNA to fragments mainly between
5 bp and 100 bp in size. The reaction setup was as fol-
lows: 1 μg genomic DNA, 1 μl 10X MNase Buffer, 0.1 μl
100X BSA in a 10 μl reaction volume was incubated
with enzyme for 15 min at 37 °C. The enzyme was im-
mediately inactivated through addition of 1 μl EGTA
(500 mM). Following addition of 4 μl gel loading dye
(Invitrogen), the reactions were run on a 20 % PAGE gel
(Invitrogen). DNA ranging from 15 to 30 bp was excised
from the gel and extracted using the Crush-and-Soak
method [34]. Briefly, the gel was crushed using a sterile
pipette tip and incubated in PAGE solubilisation buffer
(0.5 M ammonium acetate, 10 mM magnesium acetate,
1 mM EDTA pH8) at 37 °C for 16 h and purified using a
standard phenol-chloroform extraction and ethanol pre-
cipitation. Subsequently, DNA ends were repaired using
the Quick Blunting kit (NEB) in a 15 μl reaction accord-
ing to the manufacturer’s instructions.
A pair of adaptors for cloning the end-repaired DNA
fragment into vector pgRNA-pLKO.1 via a Gibson reac-
tion was amplified from the vector pgRNA-pLKO.1
using primers 5′-linker-F (5′-ttggaatcacacgacctgga and
5′-linker-R (5′-cggtgtttcgtcctttccac and 3′-linker-F (5′-
gttttagagctagaaatagcaagttaaaata) and 3′-linker-R (5′-
actcggtcatggtaagctcc) respectively. Reactions were set-up
as follows: 25 μl Phusion High-Fidelity PCR Master Mix
with HF Buffer (NEB), 2.5 μl of each primer (100 μM),
0.1 ng pgRNA-pLKO.1 in a total reaction volume of 50 μl.
Cycling conditions: 1 cycle 98 °C for 30s, 32 cycles 98 °C
for 10s, 59 °C for 10s, 72 °C for 30 s, followed by final
elongation at 72 °C for 10 min. Fragments were purified
using Agencourt AMPure XP beads (Beckman Coulter).
To prevent self-ligation of the linkers and ensure
directionality of the ligation, the 5′ linker (689 bp) was
digested with HindIII and a 600 bp fragment purified
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from a 1 % agarose gel using the Gel Extraction kit
(QIAGEN). The 3′ linker (848 bp) was digested with
SacII and the resulting 300 bp fragment gel-purified.
Next, the linkers were ligated to the fragments of MNase-
digested genomic DNA. 14 μl ligation reactions were set
up with equimolar amounts of MNase-digested fragments
(5 ng) to linkers using 1.4 μl concentrated T4 DNA ligase
(NEB) and incubated at 16 °C for 16 h. Ligation reactions
were directly used in nick translation, supplementing with
25 μl Long Amp Taq 2X Master Mix (NEB) and 2.5 μl
primer Linker-Minus450-F (10 μM, 50-GGGCAAGTTT
GTGGAATTGG) 2.5 μl primer Linker-Plus275-R (10 μM,
50- AAGTGGATCTCTGCTGTCCC) in a 50 μl reaction.
Cycling conditions were 1 cycle at 72 °C for 20 min, and
3 cycles of 95 °C for 5 min, 95 °C for 15 s, 58 °C for 15 s,
72 °C for 1 min and final elongation at 72 °C for 10 min.
Reactions were cleaned up with Agencourt AMPure XP
(Beckman Coulter) using a sample:bead ratio of 1:1 and
eluted in 40 μl of water.
Three different fragments (L1, L2 and L3) were ampli-
fied from the nick-translation product, using Phusion
High-Fidelity PCR Master Mix and HF Buffer (NEB) in a
25 μl reaction supplemented with 2.5 μl of 10 μM
primer and 1/16th of the purified product of nick trans-
lation (2.5 μl) as input. Primers Linker-Minus450-F and
Linker-Plus275-R (sequence above) yield the full-length
fragment (referred to as L1). The L2 fragment is ampli-
fied using Linker-Minus450-F and Linker-Plus160-R (5′-
TCTTTCCCCTGCACTGTACC), and L3 is amplified
using primers Linker-Minus150-F (5′-CCTTCACC-
GAGGGCCTATTT) and Linker-Plus160-R. Amplifica-
tion program: 1 cycle at 98 °C for 30 s, and 16 cycles of
98 °C for 10s, 63 °C for 10 s, 72 °C for 15 s, and final
elongation at 72 °C for 10 min. The L1, L2 and L3 amp-
lification products were analyzed on a 0.8 % low-melting
agarose gel. DNA of the correct size (869, 764 and
464 bp respectively) was excised from the gel and puri-
fied using the Gel Extraction kit (QIAGEN). The vector
pgRNA-pLKO.1 was cut with AgeI (NEB), gel-purified
and dephosphorylated using shrimp antarctic phosphat-
ase (NEB). The three linker amplicons (L1, L2 and L3)
were each cloned into the vector by Gibson assembly.
Gibson assembly master mix was prepared as described
[35]. 100 ng cut vector and insert in 2-fold molar excess
(total volume 5 μl) were added to 15 μl of Gibson master
mix and incubated at 50 °C for 1 h. A total of 16 separ-
ate reactions were set up for each type of insert and
combined for purification with the Reaction Cleanup kit
(QIAGEN), followed by electroporation of the entire
reaction into freshly prepared electrocompetent TG1 E.
coli cells with high competency (>10^10 colony-forming
units per μg DNA as determined by control electropor-
ation with pUC19 plasmid (NEB)). E. coli cells were
allowed to recover in antibiotic-free medium for 1 h at
37 °C before plating on antibiotic containing 2TY-coated
plates (Bio-assay dish with lid, 245 mm× 245 mm ×
25 mm, radiation sterilized, Thermo Scientific Nunc).
Following overnight incubation at 37 °C, the bacteria
were harvested by scraping and the plasmid library ex-
tracted using the HiSpeed Plasmid Maxi Kit (QIAGEN).
CORALINA library QC by sequencing
Fragments comprising the gRNA protospacer sequence
were amplified from the library and Illumina adapters
ligated, followed by addition of barcoded sequencing
adapters by PCR and sequencing on the Illumina MiSeq
platform. Please see Additional file 1: Supplementary
Methods for details.
Bioinformatic analysis
gRNA protospacer sequences were extracted from the raw
reads using Cutadapt [36]. Sequences were aligned to the
reference genome (human hg19 or mouse mm10 respect-
ively) using Bowtie (version 1.1.2) without allowing mis-
matches [37]. gRNAs were assessed for their length,
presence of a PAM sequence immediately downstream of
the target site and location of the targeting site in gene,
intergenic regions, and repeats, as well as GC content. To
estimate the gRNA number from the sequenced samples
of CORALINA libraries, we used a Bayesian approach.
Please see Additional file 1: Supplementary Methods
for details. The Code is available at hmgubox (https://
hgmubox.helmholtz-muenchen.de:8001/d/6c6e75236e/;
password: Coralina).
Functional validation of gRNAs with extended protospacers
NGS: gRNAs aligning to a single genomic site contain-
ing an NGG PAM and possessing protospacer longer
than 30 bp were randomly selected from the human L1
library. gRNAs were cloned into px458 (Addgene
plasmid 48138), containing an expression cassette for
S.Pyogenes Cas9-GFP. The resulting plasmids were
transfected into HEK293T cells (ATCC 293 T/17, CRL-
11268) and DNA harvested 48 h after transfection
using the DNeasy blood and tissue kit (QIAGEN).
gRNA target regions were amplified by PCR and se-
quenced by next-generation sequencing. Data was ana-
lysed using the CRISPR-parsr pipeline for indel scoring
(https://github.com/UCL-BLIC/crispr-parsr/releases/
tag/v0.2.1). For details including primer sequences
please see Additional file 1: Supplementary Methods.
Flow cytometry: Additionally, gRNAs with extended
protospacers targeting YFP were designed and cloned
into px459 (Addgene plasmid 48139). The vectors were
transiently transfected into mouse neural stem cells con-
stitutively expressing an YFP transgene (see Additional
file 1: Supplementary Methods). YFP expression was
assayed 7 days after transfection by flow cytometry.
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Results
To demonstrate the utility of CORALINA, we cloned mul-
tiple complex gRNA libraries (the study design is shown in
Fig. 1a). While CORALINA gRNAs could be derived in
principle from any source of DNA (e.g. genomic DNA
from any prokaryotic or eukaryotic species, pre-digested
DNA for reduced representation, immune-precipitated
DNA, amplified cDNA, isolated mtDNA, ctDNA, ccfDNA
or viral DNA) we used complete genomic DNA from two
very large and well annotated genomes (Mus musculus and
Homo sapiens) to test the optimal conditions, limits, and
bottlenecks of our method. For validation and replication,
we independently generated and analyzed three pooled
gRNA libraries from both species to assess the reproduci-
bility of CORALINA. In addition, CORALINA was tested
for robustness to customization (e.g. different cloning strat-
egies or delivery systems) by using different oligonucleotide
linkers for the three libraries (L1, L2 and L3, Fig. 1a).
Fig. 1 Overview of CORALINA (comprehensive gRNA library generation through controlled nuclease activity). a Three CORALINA libraries (L1, L2, L3)
from genomic DNA of human and mouse each were generated and analyzed by NGS to compare conditions and corroborate the reproducibility
of the method. b In principle, any type of double stranded DNA can be used as a source for CORALINA library generation. The DNA is fragmented
through controlled digestion with MNase and ligated to linker oligos containing only one blunt end, but no phosphate residue. Consequently,
linkers aligning in wrong orientation or to linker-oligos instead of fragments are excluded. PCR amplification allows size selection of those sequences
containing two different linker sequences. Three different linker sequences (L1, L2, L3) have been used for bulk incorporation into gRNA-PLKO.1
using Gibson Assembly (p: phosphate residue; blue, grey lines: linker sequences and homology regions on gRNA-PLKO.1; orange lines: protospacer
sequences, small arrows: primer sequences). c The analyzed representative samples of the three generated human CORALINA libraries have little
sequence overlap indicating large library complexity. Shown in numbers are the unique occurrences of protospacers longer than 17 bps
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An ultimate source of gRNA libraries allowing un-
biased genome-wide screening would contain all possible
protospacer sequences found in the genomic DNA of
the species in which the screen is conducted. Therefore,
we tested several methods (sonication and digestion with
DNAse and MNase) for controlled fragmentation of
genomic DNA. Ultrasonic degradation proved to be
inadequate to obtain small (~20 bp) DNA fragments and
DNAse digestion was poorly controllable (Additional
file 2: Figure S1A). By comparison, 7.5 Units of micro-
coccal nuclease (MNase), a commonly used prokaryotic
enzyme with minimal cleavage preferences reproducibly
digested 1 μg of genomic DNA into 10–200 bp frag-
ments when incubated at 37 °C for 15 min (Fig. 2a). This
enabled us to obtain DNA fragments of the desired size
(between 20 and 30 bp) by size separation and extraction
from 20 % PAGE gels (Fig. 2b). Following gel excision,
fragments were recovered from the gel using the Crush-
and-Soak method [34]. Subsequent purification by
phenol-chloroform and repair of 5′ and 3′ ends repro-
ducibly yielded around 2 % of the starting amount,
which for the following experiments was equivalent to
approximately 300 ng, representing approximately a
100000-fold coverage of a typical mammalian genome.
Generation of high complexity lentiviral gRNA pools
relies mainly on efficient cloning of targeting sequences
into an expression vector. Therefore, we initially modi-
fied the 2nd generation lentiviral expression vector
PLKO.1 and included, instead of the commonly used
shRNA expression cassette, the U6 promoter, the gRNA
stem loop and terminator sequences (from plasmid
MLM3636) and refer to hereafter as “gRNA-PLKO1”
(Fig. 1b). This construct enables the efficient cloning of
any chosen gRNA targeting sequence downstream of the
promoter and upstream of the gRNA stem loop using
Gibson assembly [35]. To enable efficient assembly of
complex pools of genomic DNA fragments into gRNA-
PLKO1, linker sequences providing homology to the
plasmid were ligated to the fragmented genomic DNA
(Fig. 1b). For this step, 5′- and 3′-linker fragments were
amplified from gRNA-PLKO.1 by PCR. Amplified linkers
were digested with restriction enzymes cutting at the ex-
ternal ends of the linkers to provide directionality to the
blunt end ligation reaction, which adds one linker to
each repaired end of the digested double stranded gen-
omic DNA fragment (Additional file 2: Figure S1B). Due
to lack of 5′phosphate groups at the linker amplicons
linker-to-linker ligation does not occur. Given that only
fragmented genomic DNA provides 5′phosphates for
ligation, a nick translation step was necessary to ‘seal’
the ligation products. After PCR, fragments containing
both linkers were size-selected and inserted into the
gRNA vector gRNA-PLKO.1 via Gibson assembly (Fig. 1b).
To investigate the reproducibility of the CORALINA
protocol for different cloning strategies and the impact of
different overhang sequences on the efficiency of library
assembly we used three primer pairs yielding differently
sized amplicons L1, L2 and L3 (Fig. 1 and Materials and
Methods). The three amplicons were used in 16 Gibson
assembly reactions each to incorporate human and mouse
genomic DNA into the lentiviral gRNA expression vector
efficiently. Following a reaction cleanup, the purified
Gibson assembly reactions were electroporated into
freshly prepared highly competent bacteria (>10^10
Colony-forming units/ ug DNA) from which the plasmid
library was extracted (see Materials and Methods).
The scale and consistency of the generated gRNA
libraries generated was analyzed individually for the
human L1, L2 and L3 libraries and as pools for the
three (L1-L3) mouse libraries through next generation
sequencing (Fig. 1a). The high expected complexity of
CORALINA libraries made a complete description of
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Fig. 2 a Controlled digestion of genomic DNA enables generation of fragments with predictable length (<100 bp). b Size selection of fragments
between 20 and 30 bp using polyacrylamide gels and excision
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all contained gRNA sequences an intricate matter, since
read numbers required for sufficient coverage can only
be obtained at vast expenses. Instead, we aimed to pro-
duce representative information from each cloned library
through sequencing of a gRNA subset (up to 10^6 reads).
This proved not only to be sufficient to determine the effi-
ciency and reproducibility of the method and to analyse
structural features of the generated gRNAs, it also enabled
us to investigate the distribution, the genomic categories
and the specificity of gRNA targeting sites and even
allowed us a rough estimation of gRNA numbers in the
original library pool (see below).
First, obtained sequencing reads were analyzed for
gRNA protospacer sequences, the only variable part
within the vector library; next, we determined their
lengths. The lengths of protospacers are critical, since
short gRNAs (e.g. with less than 18 bp protospacer),
although still potentially functional in targeting Cas9 to
genomic DNA, are on average less likely to possess
single genomic targeting sites. Figure 3 shows that a
vast majority of CORALINA gRNAs contains protospacer
of 18 bp or longer. Each of the generated CORALINA
libraries possessed an average protospacer length of
26–29 bp and only a low proportion of vectors lacking
functional protospacers at all, indicating high reprodu-
cibility of the method and only a moderate effect of the
used linker sequences on the efficiency of the method
(Fig. 3 a, b, Additional file 3: Figure S2). Since a propor-
tion of CORALINA gRNAs contained protospacers lon-
ger than 30 bps, we examined whether these elongated
gRNAs would still be able to guide Cas9 to genomic
targeting sites. We tested this using two independent
assays based on flow cytometry and next-generation se-
quencing, respectively (Fig. 4a and b). By employing
neural stem cells constitutively expressing the YFP
transgene, we show, that designed gRNAs targeting
YFP, but with protospacer lengths of 35 or 40 bp
(gRNA Y1-35, gRNA Y1-40, gRNA Y2-40) efficiently
induce functional knockouts of YFP when combined
with S.pyogenes Cas9 (Fig. 4a).
We next assayed five randomly selected elongated
gRNAs mapping to unique genomic sites followed by
NGG PAMs from the human CORALINA libraries (L1).
These gRNAs possessed targeting sites inside or close
to the genes PXDC1 (gRNA P1-44), HS3ST3B1 (gRNA
H1-46), PCDH8 (gRNA P2-40), ZNF790 (gRNA Z1-35)
A C E
B D F
Fig. 3 Analysis of CORALINA gRNAs. Next generation sequencing of CORALINA libraries have been used to analyze generated libraries. a, b
Quantification of protospacer length of human (a, L1) and mouse (b, “pooled”) gRNA libraries. Protospacers are mostly between 18 and 36 bp
long. Shown are protospacer lengths detected by forward (black) and reverse (grey) sequencing reads. c, d Proportions of human (c) and mouse
(d) CORALINA gRNA protospacer aligning to genomic sites containing functional PAMs of published Cas9 proteins. e, f Distribution of sequenced
gRNA protospacer alignments to the human (e) or mouse (f) genome. While the number of associated CORALINA gRNAs (black bars) is overall
correlating to the size of the respective human chromosome (white bars), GC- and gene-rich chromosomes (grey bars, 16, 17, 19) are overrepresented
relative to their size
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and PIK3AP1 (gRNA P3-35) respectively. As shown in
Fig. 4b, c and Additional file 4: Figure S4 A-E these
gRNAs (containing protospacer of 35 to 46 bp in
length) are able to induce targeted mutagenesis when
co-expressed with S.pyogenes Cas9 in human cells. The
mutations were structurally similar to those produced
using shortened versions of the same gRNAs containing
20 bp protospacer (e.g. gRNA P1-20) resulting in the three
types of CRISPR indels (deletions, insertions and complex
mutations, Fig. 4b, c and Additional file 4: Figure S4).
Fig. 4 Functional analysis of CORALINA gRNAs. a Top: Overview of gRNAs used in experiments to target YFP. gRNA Y1-35, gRNA Y1- 40, gRNA
Y2-40 target YFP and contain protospacer with 35 or 40 bp length respectively. Bottom: Flow cytometry reveals that gRNAs with long protospacer
(35 or 40 bp) efficiently target the Cas9 protein and induce mutations (detected through YFP loss, transfection rate ca. 30 %). b Top: Schematic
depicting a CORALINA derived gRNA targeting the third last intron of the human gene PXDC1 (gRNA P1-44, 44 bp protospacer). gRNA P1-20 is
trimmed from the 5′ end to yield a 20 bp protospacer. Below: Bargraph depicting percentage of NGS reads displaying indels resulting from
coexpression of wild-type Cas9 with the two gRNAs in HEK293T cells. While NGS sequencing reads of control cells reveal only wildtype sequences,
reads derived from cells transfected with gRNA P1-20 or gRNA P1-44 (and S. Pyogenes Cas9) displayed genetic alteration around the targeting
sites. Bottom: Microscopy images indicating transfection efficiency is ca. 30 %. c List of the most frequently sequenced alterations generated with
gRNA P1-44 and classified as WT (wild-type), INS (insertion), DEL (deletion) or COM (complex). Complex cases relate to cases where more than
one insertion or deletion has happened. The sequence highlighted with capital letters correspond to the target of the guide RNA. For insertions
and complex events, the ‘>’ ‘<‘mark the location of the event. See Additional file 4: Figure S4A for alterations induced by gRNA P1-20
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Subsequently, we used the information of the se-
quenced library reads to obtain a rough estimate of li-
brary complexity. For this we utilized the frequency of
single protospacer sequences obtained during the NGS
run. The estimate is based on the following rationale:
The lower the complexity of the underlying CORALINA
library, the more often individual protospacer should be
sequenced more than once. However, obtained se-
quenced samples of each of the four CORALINA librar-
ies contained mainly “singular” sequences (ca. 80–90 %,
Additional file 5: Table S1) that were only represented
by a single read in the sequencing experiment. More-
over, sequenced samples of the three human CORA-
LINA libraries analyzed by NGS also have very few
sequences in common (Fig. 1c). Both of this indicated
that CORALINA libraries exhibit a far higher number of
different protospacer sequences than sequencing reads
obtained (ca.10^6) and consequently likely represent a
considerable proportion of the genome. To confirm this
finding we extrapolated library complexity from the se-
quencing data using a Bayesian model ([38] see Material
and Methods)), which suggests a library size of 5×10^7–
10^9 individual gRNA sequences.
Next, we used Bowtie [37] to align the obtained gRNA
protospacer sequences to the mouse and human reference
genomes and to determine their genomic distribution. To
predict how useful each of the generated CORALINA li-
braries would be in conjunction with the different pub-
lished classes of Cas9 variants, we determined the
proportion of gRNA sequences possessing genomic target-
ing sites followed by a functional PAM. The libraries pre-
sented here contain scaffolds specific to S. Pyogenes Cas9
proteins and variants (for which up to 40 % of targeting
sites could be functional, containing PAMs with ‘NAG’,
‘NGG’, ‘NGA’ and ‘NGCG’ [4, 39] and ca. 23–30 % contain
a canonical S. Pyogenes PAM (‘NAG’, ‘NGG’)). As depicted
in Fig. 3 c, d (and Additional file 3: Figure S2), a majority
of individual gRNA sequences of both, mouse and human
CORALINA sequences would with minor adjustments of
the vectors also be adaptable to other published Cas9 vari-
ants [40, 41]. Moreover, the proportions of individual
PAM sequences are similar between human and mouse
CORALINA sequences and almost identical among the
three human libraries indicating reproducibility both,
among and between species (Additional file 3: Figure S2).
To quantify the distribution of gRNA targeting sites
we mapped the obtained sequences to the human and
mouse genomes. Figure 3e and f shows that gRNA
protospacers are derived from each chromosome includ-
ing gonosomes and the mitochondrial genome. The
chromosomal distribution of gRNA targeting sites is al-
most identical for the three human CORALINA libraries
(Fig. 3, Additional file 3: Figure S2) despite the lack of
shared protospacer sequences in the analyzed NGS
samples, indicating a high reproducibility of the method
(Fig. 1c). While the numbers of individual gRNA tar-
geting sites are generally correlating to the size of the
chromosomes, it is also apparent that chromosomes
overrepresented in gRNA numbers in all three human
CORALINA libraries are those harboring a particular
high GC content (and also a high relative amount of
genes, e.g. human Chr. 16, 17 and 19, but not gene-poor
Chr. 13 and 18). This effect is less pronounced in the
CORALINA library generated from the relatively GC-
rich mouse genome. This slight genomic skew and the
elevated average GC content of the gRNA libraries (48–
62 %, Additional file 5: Table S1) might be derived from
a cleavage preference of Micrococcal nuclease, since the
AT content 5′ and 3′ to the cloned cutting sites appear
increased [42] (Additional file 6: Figure S5). To rule out
a functional bias in the CORALINA method we grouped
the mapped sequences according to annotation categor-
ies (Fig. 5 and Additional file 7: Figure S3). Analysis re-
veals that a large proportion of the CORALINA gRNAs
possesses targeting sites inside genes (promoter, exons
and introns: 59 % (human L1), 40 % (mouse); as a com-
prehensive example for their distribution on a complex
gene unit, see Fig. 6). Most genes associated with proto-
spacer are encoding proteins (coding transcription units:
55 % (human L1), 35 % (mouse); noncoding transcrip-
tion units: 5 % (human L1), 5 % (mouse), Fig. 5). gRNAs
specific for multi-copy domains (like transposons, retro-
viral, simple, tandem or interspersed repeats) are present
in the generated libraries, but relative to their genomic
distribution underrepresented (human 29 %, mouse
47 %, Fig. 5). Differences between the human and mouse
libraries, specifically in the distribution of protospacers
representing particular repeat classes, can likely be ex-
plained by their different genomic composition [43, 44].
Importantly, despite the lack of shared protospacer
sequences in the analyzed NGS samples of the three hu-
man CORALINA libraries (Fig. 1c), genomic categories
are almost equally represented among the gRNA target-
ing sites, indicating high reproducibility and robustness
of the method (Multinomial equivalence test, confidence
value 0.99, Material and Methods). To investigate the
specificity of the obtained gRNA sequences we deter-
mined for each of them the number of potential target-
ing sites in the appropriate genome. As expected, gRNA
protospacer associated with repeat sequences (simple,
low complexity, LTR, SINE or LINEs) often contain
several genomic binding sites (represented by a relative
high median of target sites, human L1: 4, mouse: 6). In
contrast, gRNA sequences targeting human coding
genes possess often a single genomic targeting site (rep-
resented by a median of 1, Fig. 5). While this is espe-
cially predominant in exonic sequences, even gRNAs
targeting promoters (median target sites: 1), introns (2),
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noncoding gene units (2) and non-annotated regions
(other, 1) have often unique targeting sites (Fig. 5). This
relative high specificity of CORALINA gRNAs (even
comparable to published gRNAs or synthetized gRNA
libraries) has been independently validated by deter-
mination of established in silico quality scores (Fig. 5c,
[45]). Thus, excellent coverage and satisfactory specifi-
city indicate a high potential for CORALINA libraries
in a large number of approaches.
Discussion
We present here a new, simple, time- and cost-effective
method to generate high complexity gRNA libraries
from any source of DNA (CORALINA). The presented
method is not only applicable to uncommon model sys-
tems; it also does not depend on the availability of reli-
able sequence information. As a proof of principle, we
generated CORALINA libraries from two large mamma-
lian genomes, Mus musculus and Homo sapiens,
A
B
C
Fig. 5 Analysis of CORALINA libraries. Bowtie has been used to classify targeting sites of gRNAs derived from human (L1, a) or mouse (“pooled”,
b) CORALINA libraries. Pie charts indicating relative proportion of functional domains bound by gRNAs (middle). gRNA protospacer aligning to
coding gene units (left) or repeats (right) are further sub-classified. Promoters are defined here as genomic sequences between 10 kb upstream to
the transcriptional start site. Coding and noncoding gene and repeat information has been derived from UCSC. Numbers next to the sectors depict
the median number of genomic alignments for the selected group of gRNAs. c Depiction of average specificity score of CORALINA libraries calculated
according to [45] and compared to available gRNAs (Addgene) and a published gRNA library [49]. Error bars depict the standard error of the mean
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determined the obtained sequences through next gener-
ation sequencing and used cross species validation to
confirm its reproducibility. Supported by a recent publi-
cation elegantly constructing gRNAs from a prokaryotic
genome (E. Coli) [29] we show that employing nucleases
is a highly efficient approach for gRNA library gener-
ation (CRISPR EATING). In both approaches only a
minority of gRNAs contain a PAM for a specific Cas9
variant when libraries are generated. In contrast to
CRISPR EATING, however, CORALINA libraries have
the potential to contain more possible gRNA sequences
for one single Cas9 variant (e.g. S.Pyogenes, Additional
file 6: Figure S5). Bioinformatic and statistical analysis
revealed that CORALINA yields high complexity librar-
ies (5×10^7–10^9) comprehensively covering the gen-
ome. The obtained protospacers represent all genomic
classes including mitochondrial, ribosomal, regulatory,
coding and noncoding transcription units. Screening
with CORALINA will allow the revelation of functional
hits from both, single copy regions and classes of multi-
copy sequences (the value of which recently has been
impressively demonstrated [46]), through the versatility
of the generated libraries.
While CORALINA allows the efficient and cost-
effective cloning of virtually all functional gRNA se-
quences from a specific genome, those also contain gRNA
sequences, which, due to the lack of PAM sequences, are
not able to guide Cas9 proteins to their targeting sites.
While this specific shortcoming is a direct consequence of
the high complexity of CORALINA libraries, its negative
impact can likely be diminished. Since gRNAs lacking
PAMs are not biologically active, increased cell number or
gRNA number per cell (e.g. through higher MOI) would
not necessarily interfere with screening. Since PAMs are
easy to determine in silico, those gRNAs without could
even serve as negative controls helping to determine
thresholds for candidate hits and make ‘spiked in’ negative
controls obsolete. Furthermore, since several laboratories
currently work on Cas9 variants being dependent on new
PAM sequences (or none at all) the momentary disadvan-
tage of CORALINA libraries could eventually turn into an
advantage [39–41, 47]. Indeed, CORALINA gRNAs pos-
sess targeting sites containing all PAM sequences pub-
lished to date making this method in principle applicable
for each Cas9 variant and even combinatorial use. As part
of the bioinformatics analysis, protospacer lengths of
CORALINA gRNAs were analysed as well. Conventionally
designed gRNAs usually contain a protospacer of 20 bp,
since shorter protospacer have often multiple on-target
sites (and thus are less specific). CORALINA generates
gRNAs with relatively long targeting sequences (between
18 and 40 bps, Fig. 3), which, as shown here, are func-
tional in targeting the CRISPR complex (Fig. 4 and
Additional file 4: Figure S4).
Each screening approach is different; some experi-
mental setups might not be adaptable to large scale ap-
proaches and few might allow screening a mammalian
genome to saturation. However, for some approaches
(e.g. those with low false positive rates) CORALINA
could allow for the first time the discovery of functional
hits without an intense bias to few targeting sites and
ORFs. Moreover, we envision that using multiple
rounds of reiterative screening would make CORA-
LINA applicable to many positive selection screens. If
after each round of screening, gRNA constructs are ex-
tracted from selected cells and used as templates for
the generation of subsequent gRNA libraries, true posi-
tive hits would continuously propagate while library
complexity decreases with every round. Since CORA-
LINA can in principle be applied to any source of
Fig. 6 Visual representation of protospacer alignments to a ribosomal gene unit. Shown are sequences detected in the sequencing reads of
three human CORALINA libraries (L1, L2, L3) which correspond to a ribosomal gene unit on chromosome 21. Alignments to the positive DNA
strands are shown above, those to the negative DNA strand below the gene structure using the UCSC genome browser (blue from left to right:
5′ETS, ITSs, 3′ETS; orange: 18S rRNA, 5.8S rRNA, 28S rRNA)
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DNA, the achieved library complexity decreases with
the complexity of the input DNA. While the genomes
used here for proof of principle experiments belong to
the largest ones studied, most model organisms possess
considerably smaller genomes. The libraries generated
here contained all genomic classes comprehensively
(including coding and non-coding transcripts, exons,
introns, gene promoters, mitochondrial sequences and
other features) indicating that genomic subsets (ChIPed
DNA, mtDNA, reduced representation DNA) would be
a suitable input for targeted CORALINA libraries in
the future.
Conclusions
The development of CORALINA makes it possible to
generate pools of virtually genome-wide gRNA libraries
at low cost. This allows not only conducting functional
screens at an unmatched genomic depth, but simultan-
eously makes approaches possible that have been so far
impractical. CORALINA enables first of all a simple
generation of large scale libraries from any source of
DNA (including species lacking reliable sequence infor-
mation). Secondly, CORALINA allows genetic screens
for functional non-coding transcripts and elements, a
highly promising approach so far only practical on in-
dividual genomic elements [32]. Third, through the use
of enzymatic inactive Cas9 variants shuttling chromatin
modifying enzymes to defined genomic sites, CORA-
LINA might also allow the implementation of genome-
wide epigenetic screens. Since a large proportion of the
genome is suspected to play a regulatory role [48] these
approaches inherently depend on genuine genome-
wide libraries.
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Additional file 1: Supplementary methods. Supplementary information
to bioinformatic and statistical analysis, primer sequences and
supplementary methods. (PDF 276 kb)
Additional file 2: Figure S1. (A) DNAse digestion (left) or sonication
(right) has proven inappropriate for the controlled and efficient
generation small (<30 bp) DNA fragments from genomic DNA. (B)
Overhang adapters enabling Gibson assembly have been generated
using PCR (left side) and cut (right side) to produce asymmetric linker
ends (see Fig. 1). (PDF 2811 kb)
Additional file 3: Figure S2. Analysis of CORALINA gRNAs. Next
generation sequencing of CORALINA libraries have been used to analyze
generated libraries. (A, B) Quantification of protospacer length of human
L2 (A, C, E) and L3 (B, D, F) gRNA libraries. Protospacers are mostly between
18 and 36 bp long. Shown are protospacer lengths detected by forward
(black) and reverse (grey) sequencing reads. (C, D) Proportions of CORALINA
gRNAs aligning to genomic sites containing functional PAMs of published
Cas9 proteins. (E, F) Distribution of sequenced gRNA protospacer
alignments to the human genome. While the number of associated
CORALINA gRNAs (black bars) is overall correlating to the size of the
respective chromosome (white bars), GC- and gene-rich chromosomes
(grey bars, 16, 17, 19) are overrepresented relative to their size. (PDF 70 kb)
Additional file 4: Figure S4. Functional analysis of CORALINA gRNAs.
(A) List of most frequently sequenced alteration generated with gRNA
P1-20. (B-E) Top: Schematic depicting CORALINA-derived gRNAs targeting
regions in or near various human genes (HS3ST3B1 gRNA H1-46, 46 bp
protospacer, PCDH8, gRNA P2- 40, 40 bp protospacer, ZNF790, gRNA Z1-35,
35 bp protospacer, PIK3AP1, gRNA P3-35, 35 bp protospacer). Control
gRNAs have been shortened from the 5′ end to yield a 20 bp protospacer.
Right: Bargraph depicting percentage of NGS reads displaying indels after
targeting wild-type Cas9 using CORALINA-derived gRNAs in HEK293T cells.
Below: List of the most frequently sequenced alterations generated by
CORALINA and control gRNAs. (PDF 320 kb)
Additional file 5: Table S1. Quantification of NGS read number and GC
content for the four analysed NGS sequencing samples. (PDF 19 kb)
Additional file 6: Figure S5. Comparison of CORALINA libraries to an
alternative method used for the generation of large-scale gRNA libraries
targeting the E.coli genome (CRISPR-EATING) [29]. (A) Theoretical number
of E.coli gRNAs with S.Pyogenes PAM sequences accessible to CRISPR-
EATING and CORALINA respectively. (B) GC content of the different gRNA
libraries and of the genomes they were generated from. (C) Nucleotide
frequency at the 5′ and 3′ ends of the gRNAs incorporated into libraries
corresponding to the cutting sites of the nucleases/restriction enzymes
used. (PDF 40 kb)
Additional file 7: Figure S3. Analysis of CORALINA libraries. Bowtie has
been used to classify targeting sites of gRNAs derived from human (L2,
A or L3, B) CORALINA libraries. Pie charts indicating relative proportion
of functional domains bound by gRNAs (middle). gRNA protospacer
aligning to coding gene units (left) or repeats (right) are further sub-
classified. Promoters are defined here as genomic sequences 10 kb
upstream the transcriptional start site. Coding and noncoding gene
and repeat information has been derived from UCSC. Numbers next to
the sectors depict the median number of genomic alignments for the
selected group of gRNAs. (PDF 73 kb)
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